Submission for OMB Review; 30-Day Comment Request: Request Human Embryonic Stem Cell Line To Be Approved for Use in NIH Funded Research (Office of the Director), 56078 [2022-19775]
Download as PDF
<![CDATA[
56078
Federal Register / Vol. 87, No. 176 / Tuesday, September 13, 2022 / Notices
Genome Research Institute, National
Institutes of Health, 6700B Rockledge Drive,
Room 3189, Bethesda, MD 20892, (301) 435–
1580, mckenneyk@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.172, Human Genome
Research, National Institutes of Health, HHS)
Dated: September 8, 2022.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2022–19747 Filed 9–12–22; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Submission for OMB Review; 30-Day
Comment Request: Request Human
Embryonic Stem Cell Line To Be
Approved for Use in NIH Funded
Research (Office of the Director)
AGENCY:
National Institutes of Health,
HHS.
ACTION:
Notice.
In compliance with the
requirement of the Paperwork
Reduction Act of 1995, the National
Institutes of Health (NIH) Office of the
Director has submitted to the Office of
Management and Budget (OMB) a
SUMMARY:
request for review and approval of the
information listed below.
DATES: Comments regarding this
information collection are best assured
of having their full effect if received
within 30 days of the date of this
publication.
ADDRESSES: Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the data collection plans and
instruments, contact: Dr. Ellen Gadbois,
Office of the Director, NIH, building 1,
Room 218, MSC 0166, 9000 Rockville
Pike, Bethesda, Maryland 20892, or call
non-toll free number (301) 496–9838 or
email your request, including your
address to: Ellen.gadbois@nih.gov.
SUPPLEMENTARY INFORMATION: This
proposed information collection was
previously published in the Federal
Register on June 8, 2022, pages 34892–
34893 (87 FR 34892) and allowed 60
days for public comment. No public
comments were received. The purpose
of this notice is to allow an additional
30 days for public comment.
The NIH Office of the Director may
not conduct or sponsor, and the
respondent is not required to respond
to, an information collection that has
been extended, revised, or implemented
on or after October 1, 1995, unless it
displays a currently valid OMB control
number.
In compliance with section
3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the National
Institutes of Health (NIH) has submitted
to the OMB a request for review and
approval of the information collection
listed below.
Proposed Collection: Request for
Human Embryonic Stem Cell Line to Be
Approved for Use in NIH Funded
Research. OMB No. 0925–0601
Extension —Expiration Date 10/31/
2022—Office of the Director, NIH.
Need and Use of Information
Collection: This form is used by
applicants to request that human
embryonic stem cell lines be approved
for use in NIH funded research.
Applicants may submit applications at
any time.
OMB approval is requested for three
years. There are no costs to respondents
other than their time. The total
estimated annualized burden hours are
255 per respondent.
ESTIMATED ANNUALIZED BURDEN HOURS
Average time
per response
(in hours)
Total annual
burden hour
NIH grantees and others with hESC lines .......................................................
5
3
17
255
Total ..........................................................................................................
........................
15
........................
255
Dated: September 7, 2022.
Tara A. Schwetz,
Acting Principal Deputy Director, National
Institutes of Health.
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
[FR Doc. 2022–19775 Filed 9–12–22; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
jspears on DSK121TN23PROD with NOTICES
Number of
responses per
respondent
Number of
respondents
Type of respondent
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
VerDate Sep<11>2014
17:30 Sep 12, 2022
Jkt 256001
Name of Committee: Biological Chemistry
and Macromolecular Biophysics Integrated
Review Group; Synthetic and Biological
Chemistry A Study Section.
Date: October 12–13, 2022.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
PO 00000
Frm 00091
Fmt 4703
Sfmt 4703
Contact Person: Anita Szajek, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4187,
Bethesda, MD 20892, 301–827–6276,
anita.szajek@nih.gov.
Name of Committee: Genes, Genomes, and
Genetics Integrated Review Group;
Maximizing Investigators’ Research Award A
Study Section.
Date: October 12–13, 2022.
Time: 10:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Mollie Kim Manier, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (301) 594–0510, mollie.manier@
nih.gov.
E:\FR\FM\13SEN1.SGM
13SEN1
]]>Agencies
[Federal Register Volume 87, Number 176 (Tuesday, September 13, 2022)]
[Notices]
[Page 56078]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-19775]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Submission for OMB Review; 30-Day Comment Request: Request Human
Embryonic Stem Cell Line To Be Approved for Use in NIH Funded Research
(Office of the Director)
AGENCY: National Institutes of Health, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In compliance with the requirement of the Paperwork Reduction
Act of 1995, the National Institutes of Health (NIH) Office of the
Director has submitted to the Office of Management and Budget (OMB) a
request for review and approval of the information listed below.
DATES: Comments regarding this information collection are best assured
of having their full effect if received within 30 days of the date of
this publication.
ADDRESSES: Written comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to www.reginfo.gov/public/do/PRAMain. Find this particular
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the data collection plans and
instruments, contact: Dr. Ellen Gadbois, Office of the Director, NIH,
building 1, Room 218, MSC 0166, 9000 Rockville Pike, Bethesda, Maryland
20892, or call non-toll free number (301) 496-9838 or email your
request, including your address to: [email protected].
SUPPLEMENTARY INFORMATION: This proposed information collection was
previously published in the Federal Register on June 8, 2022, pages
34892-34893 (87 FR 34892) and allowed 60 days for public comment. No
public comments were received. The purpose of this notice is to allow
an additional 30 days for public comment.
The NIH Office of the Director may not conduct or sponsor, and the
respondent is not required to respond to, an information collection
that has been extended, revised, or implemented on or after October 1,
1995, unless it displays a currently valid OMB control number.
In compliance with section 3507(a)(1)(D) of the Paperwork Reduction
Act of 1995, the National Institutes of Health (NIH) has submitted to
the OMB a request for review and approval of the information collection
listed below.
Proposed Collection: Request for Human Embryonic Stem Cell Line to
Be Approved for Use in NIH Funded Research. OMB No. 0925-0601 Extension
--Expiration Date 10/31/2022--Office of the Director, NIH.
Need and Use of Information Collection: This form is used by
applicants to request that human embryonic stem cell lines be approved
for use in NIH funded research. Applicants may submit applications at
any time.
OMB approval is requested for three years. There are no costs to
respondents other than their time. The total estimated annualized
burden hours are 255 per respondent.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average time
Type of respondent Number of responses per per response Total annual
respondents respondent (in hours) burden hour
----------------------------------------------------------------------------------------------------------------
NIH grantees and others with hESC lines......... 5 3 17 255
---------------------------------------------------------------
Total....................................... .............. 15 .............. 255
----------------------------------------------------------------------------------------------------------------
Dated: September 7, 2022.
Tara A. Schwetz,
Acting Principal Deputy Director, National Institutes of Health.
[FR Doc. 2022-19775 Filed 9-12-22; 8:45 am]
BILLING CODE 4140-01-P
